BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32004973)

  • 1. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
    Zhang WJ; Hu CG; Zhu ZM; Luo HL
    Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
    Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
    Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
    Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
    Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
    Li Q; Zhu X; Song W; Peng X; Zhao R
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of purinergic P2X
    McLarnon JG
    Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
    Allsopp RC; Dayl S; Schmid R; Evans RJ
    Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
    Scarpellino G; Genova T; Munaron L
    Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
    Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
    Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells.
    Ziberi S; Zuccarini M; Carluccio M; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Di Iorio P; Ciccarelli R
    Cells; 2019 Dec; 9(1):. PubMed ID: 31905754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the relationship between P2X7R and colorectal cancer.
    Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
    Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X7 receptors: channels, pores and more.
    Volonté C; Apolloni S; Skaper SD; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
    Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
    J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
    de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
    Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research Progress in the Relationship Between P2X7R and Cervical Cancer.
    Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
    Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
    Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
    Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
    Giannuzzo A; Pedersen SF; Novak I
    Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
    Caseley EA; Muench SP; Fishwick CW; Jiang LH
    Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
    Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of P2X7 receptor in prognosis and metastasis of colorectal cancer.
    Zhang Y; Ding J; Wang L
    Adv Med Sci; 2019 Sep; 64(2):388-394. PubMed ID: 31276917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MED1101: a new dialdehydic compound regulating P2×7 receptor cell surface expression in U937 cells.
    Muzzachi S; Blasi A; Ciani E; Favia M; Cardone RA; Marzulli D; Reshkin SJ; Merizzi G; Casavola V; Soleti A; Guerra L
    Biol Cell; 2013 Sep; 105(9):399-413. PubMed ID: 23718135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.